JPH0158165B2 - - Google Patents
Info
- Publication number
- JPH0158165B2 JPH0158165B2 JP2044982A JP2044982A JPH0158165B2 JP H0158165 B2 JPH0158165 B2 JP H0158165B2 JP 2044982 A JP2044982 A JP 2044982A JP 2044982 A JP2044982 A JP 2044982A JP H0158165 B2 JPH0158165 B2 JP H0158165B2
- Authority
- JP
- Japan
- Prior art keywords
- allantoin
- water
- external preparation
- added
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 40
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 20
- 229960000458 allantoin Drugs 0.000 claims description 20
- 238000002360 preparation method Methods 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 229920002125 Sokalan® Polymers 0.000 claims description 9
- 239000004094 surface-active agent Substances 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- -1 sorbitan fatty acid esters Chemical class 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 235000019271 petrolatum Nutrition 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 239000003871 white petrolatum Substances 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 2
- 229920002884 Laureth 4 Polymers 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- NUCLJNSWZCHRKL-UHFFFAOYSA-N allantoic acid Chemical compound NC(=O)NC(C(O)=O)NC(N)=O NUCLJNSWZCHRKL-UHFFFAOYSA-N 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000008311 hydrophilic ointment Substances 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010059516 Skin toxicity Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940086737 allyl sucrose Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229960002645 boric acid Drugs 0.000 description 1
- 235000010338 boric acid Nutrition 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000438 skin toxicity Toxicity 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Description
本発明は、アラントインを主成分とする外用剤
に関するものである。ここで外用剤とは顔や手足
などのヒフを保護し健康な状態に保つために外用
する医療用および化粧用の製剤を意味する。
アラントインは化粧品原料基準に収載されてお
り、創傷、潰瘍、火傷等の手当や湿疹のような皮
膚科疾患に用いられ、通常0.1〜0.5%処方され
る。このアラントインは加水分解されやすく、例
えば酸性ではグリオキシル酸と尿素となり、アル
カリ性ではアラントイン酸に分解されることが知
られているが、その正確な定量も行なわれていな
かつたため経時的にかなりの含量減少が起つてい
たと思われる。
そこで本発明者は、アラントインを配合した外
用剤につき、含量減少が許容範囲内であり、長期
間にわたつて異臭や着色変化、粘度変化等を生じ
ず使用感の優れたものを得るため鋭意研究の結果
本発明を完成した。
すなわち本発明は、アラントインを主成分と
し、カルボキシビニルポリマーと水を含みPHを
5.5以下に調整した外用剤である。
カルボキシビニルポリマーは、化粧品原料基準
にも収載されており、アクリル酸を主とし、アリ
ル蔗糖などと共重合させたものであり、中和によ
り優れた増粘効果を奏することが知られていて、
カーボポール、ジユンロン、ハイビスワコー等の
名称で市販されている。
カルボキシビニルポリマーは一般に0.1〜10%
程度処方され、水酸化ナトリウム、水酸化カリウ
ム等の塩基性無機物またはエタノールアミン等の
塩基性有機物で中和し、PH5.5〜11としたときに
最も優れた効果が得られるとされている。しかし
ながら、本発明者の研究によりアラントインを外
用剤に配合するときは、PHが5.5をアルカリ性側
に越える場合は長期間の保存によりアラントイン
の含量が90%を下まわる例も生じることが認めら
れたので、これ以下のPHでの使用可能性を更に検
討したところ、カルボキシビニルポリマーを用い
てPHを5.5以下とした場合でもコロイド化学的に
安定なゲル状外用剤が得られ、PH緩衝作用も発揮
されることが確められた。
本発明の外用剤にはアラントインとカルボキシ
ビニルポリマーおよび水の他にも、一般に外用剤
に配合される成分を加えてもよく、例えば皮膚保
護作用を示す油成分としてワセリン、流動パラフ
イン、スクアラン等の炭化水素類、セチルアルコ
ール、ステアリルアルコール等の高級アルコール
類およびパルミチン酸、ステアリン酸等の高級脂
肪酸類が挙げられる。また保湿剤としてグルセリ
ン、ソルビトール、プロピレングリコール等、防
腐剤としてヒドロキシ安息香酸メチル等のフエノ
ール誘導体、塩化ベンザルコニウム等の逆性セツ
ケン、ソルビン酸、デヒドロ酢酸、ホウ酸等、さ
らに香料、色素等を加えてもよい。さらに、軟
膏、クリーム剤等を調製する際に乳化剤として界
面活性剤、特に合成界面活性剤がよく使用される
がこれらを加えることもできる。例を挙げるとソ
ルビタン脂肪酸エステル(スパン類)、ポリオキ
シエチレンソルビタン脂肪酸エステル(トウイー
ン類)、ポリオキシエチレングリコールアルキル
エーテル、ポリオキシエチレングリコール脂肪酸
エステル等の非イオン性界面活性剤、塩化ベンザ
ルコニウム、塩化ベンゼトニウム等の陽イオン性
活性剤、アルキル硫酸ナトリウム等の陰イオン性
活性剤等である。ただし、界面活性剤を用いると
コロイド化学的には安定なクリームを得ることが
できるが、皮膚刺激が皮膚毒性の点で界面活性剤
の使用は好ましくない。
本発明の外用剤はこれらの界面活性剤の使用が
可能ではあるが必須ではなく、配合しない場合で
も使用感に優れ、経時安定性が良い点に特徴を有
する。
製造方法としては、一般的な外用剤の製法でよ
く、例えばパラフイン、スクアラン等の油層成分
とグリセリン、プロピレングリコール、水等の水
層成分を別々に50〜80℃に加温し、その後両者を
撹拌しながら混合する。次に撹拌を続けながら室
温に到達するまで冷却する。カルボキシビニルポ
リマーは油層成分に添加させても良く、またグリ
セリン、プロピレングリコール等の水層成分に分
散させた上で添加しても均一溶解することが出来
る。
以下に実施例および比較例を示し詳細に説明す
る。
実施例
アラントイン 0.4重量部
カーボポール934 1.0 〃
スクアラン 10.0重量部
1,3―ブチレングリコール 5.0 〃
パラオキシ安息香酸エチル 0.1 〃
水酸化ナトリウム 適量
精製水 全量を100重量部とする。
スクアランにカーボポール934(グツドリツチ社
製カルボキシビニルポリマー)を均一に分散さ
せ、懸濁させた油層成分を調製する。一方精製水
を約50℃に加温し、撹拌しながらパラオキシ安息
香酸エチル、1,3―ブチレングリコールおよび
アラントインを添加し、溶解した後、さきの油層
成分を加え、10分間撹拌する。次に水酸化ナトリ
ウムを加えてPH4±0.2,5±0.2,6±0.2または
7±0.2に調整したのち撹拌しつつ室温になるま
で冷やした。
比較例 1
o/w型 親水軟膏(日本薬局方第十改正)
アラントイン 0.4重量部
白色ワセリン 25.0 〃
ステアリルアルコール 22.0 〃
プロピレングリコール 12.0重量部
ラウリル硫酸ナトリウム 1.5 〃
パラオキシ安息香酸エチル 0.025 〃
パラオキシ安息香酸プロピル 0.015 〃
精製水 全量を100重量部とする。
白色ワセリン及びステアリルアルコールを水浴
上で溶かし、かき混ぜて約75℃に保ち、これにあ
らかじめアラントインを精製水に溶かして75℃に
加温した液を加え、固まるまでかき混ぜた。
比較例 2
w/o型 吸水軟膏(日本薬局方第十改正)
アラントイン 0.4重量部
白色ワセリン 40 〃
セタノール 18 〃
セスキオレイン酸ソルビタン 5 〃
ラウロマクロゴール 0.5 〃
パラオキシ安息香酸エチル 0.1 〃
パラオキシ安息香酸プロピル 0.1 〃
精製水 全量を100重量部とする。
白色ワセリン、セタノール、パラオキシ安息香
酸プロピル、ラウロマクロゴールおよびセスキオ
レイン酸ソルビタンをとり、水浴上で75℃に加温
して溶解し、油層成分とする。別に精製水にアラ
ントインおよびパラオキシ安息香酸エチルを加え
80℃に加温して溶解した液を徐々に油層成分に加
えてかき混ぜ、加温を止め固まるまでかき混ぜ
た。
比較例1および2は第十改正日本薬局方親水軟
膏および吸水軟膏にアラントインを処方したもの
である。
上記実施例および比較例について5人のパネラ
ーに使用させ、使用時のベトツキ、のび、清涼感
の官能評価をおこなつた。
その結果は表1に示したとおりであり、実施例
の外用剤が使用時のベトツキ、のびおよび清涼感
等の官能面で最も優れている。
The present invention relates to an external preparation containing allantoin as a main ingredient. The term "external preparations" as used herein refers to medical and cosmetic preparations that are used externally to protect the face, limbs, etc., and keep them in a healthy condition. Allantoin is listed in the Standards for Cosmetic Ingredients and is used to treat wounds, ulcers, burns, etc. and for dermatological diseases such as eczema, and is usually prescribed at 0.1 to 0.5%. Allantoin is easily hydrolyzed; for example, it is known to be decomposed into glyoxylic acid and urea in acidic conditions, and to allantoic acid in alkaline conditions, but as accurate quantification has not been carried out, the content decreases considerably over time. seems to have occurred. Therefore, the present inventor conducted extensive research in order to obtain a topical preparation containing allantoin in which the content reduction is within an acceptable range, and which has an excellent feeling of use without causing any off-odor, color change, or viscosity change over a long period of time. As a result, the present invention was completed. In other words, the present invention has allantoin as the main component, contains carboxyvinyl polymer and water, and has a pH control.
This is an external preparation adjusted to 5.5 or less. Carboxyvinyl polymer is also listed in the Cosmetic Raw Materials Standards, and is mainly made of acrylic acid, copolymerized with allyl sucrose, etc., and is known to have an excellent thickening effect when neutralized.
It is commercially available under names such as Carbopol, Jiyunron, and Hibiswako. Carboxyvinyl polymers are generally 0.1-10%
It is said that the best effects are obtained when the pH is adjusted to 5.5-11 by neutralizing with basic inorganic substances such as sodium hydroxide and potassium hydroxide, or basic organic substances such as ethanolamine. However, the inventor's research has shown that when allantoin is added to external preparations, if the pH exceeds 5.5 on the alkaline side, the allantoin content may drop below 90% due to long-term storage. Therefore, we further investigated the possibility of using it at a pH lower than this, and found that even when the pH was lowered to 5.5 or lower using carboxyvinyl polymer, a gel-like external preparation was obtained that was colloidally stable and also exhibited a pH buffering effect. It was confirmed that it would be done. In addition to allantoin, carboxyvinyl polymer, and water, the external preparation of the present invention may contain other ingredients that are generally included in external preparations, such as petrolatum, liquid paraffin, squalane, etc., as an oil component that has a skin protective effect. Examples include hydrocarbons, higher alcohols such as cetyl alcohol and stearyl alcohol, and higher fatty acids such as palmitic acid and stearic acid. In addition, moisturizing agents such as glycerin, sorbitol, and propylene glycol, preservatives such as phenol derivatives such as methyl hydroxybenzoate, antiseptics such as benzalkonium chloride, sorbic acid, dehydroacetic acid, and boric acid, as well as fragrances and pigments, etc. May be added. Furthermore, surfactants, especially synthetic surfactants, are often used as emulsifiers when preparing ointments, creams, etc., and these can also be added. Examples include nonionic surfactants such as sorbitan fatty acid esters (spans), polyoxyethylene sorbitan fatty acid esters (tweens), polyoxyethylene glycol alkyl ethers, polyoxyethylene glycol fatty acid esters, benzalkonium chloride, These include cationic activators such as benzethonium chloride, anionic activators such as sodium alkyl sulfate, and the like. However, although it is possible to obtain a colloidally chemically stable cream by using a surfactant, the use of a surfactant is not preferable because it causes skin irritation and toxicity. Although the use of these surfactants is possible in the external preparation of the present invention, it is not essential, and even when they are not incorporated, the preparation is characterized by excellent feeling on use and good stability over time. The manufacturing method may be a general manufacturing method for external preparations, for example, oil layer components such as paraffin and squalane and water layer components such as glycerin, propylene glycol, and water are heated separately to 50 to 80°C, and then both are heated. Mix while stirring. It is then cooled with continued stirring until it reaches room temperature. The carboxyvinyl polymer may be added to the oil layer component, or it can be uniformly dissolved even if it is added after being dispersed in the water layer component such as glycerin or propylene glycol. Examples and comparative examples will be shown below and explained in detail. Examples Allantoin 0.4 parts by weight Carbopol 934 1.0 Squalane 10.0 parts by weight 1,3-butylene glycol 5.0 Ethyl paraoxybenzoate 0.1 Sodium hydroxide Appropriate amount Purified water The total amount is 100 parts by weight. An oil layer component is prepared by uniformly dispersing and suspending Carbopol 934 (carboxyvinyl polymer manufactured by Gutudoritsu) in squalane. Meanwhile, warm purified water to about 50°C, add ethyl paraoxybenzoate, 1,3-butylene glycol, and allantoin while stirring, and after dissolving, add the oil layer components and stir for 10 minutes. Next, sodium hydroxide was added to adjust the pH to 4±0.2, 5±0.2, 6±0.2 or 7±0.2, and the mixture was cooled to room temperature while stirring. Comparative example 1 O/W type hydrophilic ointment (Japanese Pharmacopoeia 10th revision) Allantoin 0.4 parts by weight White petrolatum 25.0 〃 Stearyl alcohol 22.0 〃 Propylene glycol 12.0 parts by weight Sodium lauryl sulfate 1.5 〃 Ethyl paraoxybenzoate 0.025 〃 Propyl paraoxybenzoate 0.015 〃 Purified water The total amount is 100 parts by weight. White petrolatum and stearyl alcohol were dissolved on a water bath, stirred, and kept at about 75°C. To this was added a solution in which allantoin had been previously dissolved in purified water and heated to 75°C, and stirred until solidified. Comparative example 2 w/o type water-absorbing ointment (Japanese Pharmacopoeia 10th revision) Allantoin 0.4 parts by weight White petrolatum 40 Setanol 18 Sorbitan sesquioleate 5 Lauromacrogol 0.5 Ethyl paraoxybenzoate 0.1 Propyl paraoxybenzoate 0.1 〃 Purified water The total amount is 100 parts by weight. Take white petrolatum, cetanol, propyl paraoxybenzoate, lauromacrogol, and sorbitan sesquioleate, and dissolve by heating to 75°C on a water bath to obtain an oil layer component. Separately, add allantoin and ethyl paraoxybenzoate to purified water.
The solution heated to 80°C and dissolved was gradually added to the oil layer components and stirred, then the heating was stopped and the mixture was stirred until solidified. In Comparative Examples 1 and 2, allantoin was prescribed in a hydrophilic ointment and a water-absorbing ointment according to the 10th edition of the Japanese Pharmacopoeia. The above Examples and Comparative Examples were used by five panelists, and sensory evaluations of stickiness, spreadability, and refreshing sensation upon use were conducted. The results are shown in Table 1, and the external preparations of Examples were the most excellent in terms of sensory aspects such as stickiness, spreadability, and refreshing feeling during use.
【表】【table】
【表】
実施例の外用剤を室温で3ケ月および40℃で3
ケ月間保存し、外観(肉眼判定)、使用感および
アラントイン含量を測定し、表2に示した試験結
果が得られた。[Table] The external preparation of the example was used for 3 months at room temperature and 3 months at 40℃.
The product was stored for several months, and the appearance (judgment with the naked eye), feeling of use, and allantoin content were measured, and the test results shown in Table 2 were obtained.
【表】
アラントイン含量は高速液体クロマトグラフイ
ー法によつて定量した。
表2からわかるとおり室温3ケ月および40゜3ケ
月の保存をとおし本発明の外用剤は、PH4〜7の
範囲に調製した各試料ともに外観変化および使用
感に変化は全く認められなかつた。しかし、アラ
ントイン含量はPH4およびPH5のものが最も優れ
ており、PH6〜7と高くするとアラントインの含
量低下が認められた。
なお、外用剤のPHを4より小さくすることはヒ
フに対して好ましくないので、PH4〜5.5に調整
するのが適当である。[Table] Allantoin content was determined by high performance liquid chromatography. As can be seen from Table 2, when the external preparation of the present invention was stored at room temperature for 3 months and at 40°C for 3 months, no change was observed in the appearance or feel of each sample prepared to have a pH in the range of 4 to 7. However, the allantoin content was the best at PH4 and PH5, and when the pH was increased to 6 to 7, a decrease in the allantoin content was observed. In addition, since it is not preferable for Hif to lower the pH of the external preparation to less than 4, it is appropriate to adjust the pH to 4 to 5.5.
Claims (1)
ルポリマーと水を含みPHを5.5以下に調整した外
用剤。 2 界面活性剤を含まない特許請求の範囲第1項
の外用剤。[Claims] 1. An external preparation containing allantoin as a main component, a carboxyvinyl polymer and water, and having a pH adjusted to 5.5 or less. 2. The external preparation according to claim 1, which does not contain a surfactant.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2044982A JPS58140013A (en) | 1982-02-10 | 1982-02-10 | Preparation for external purpose |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2044982A JPS58140013A (en) | 1982-02-10 | 1982-02-10 | Preparation for external purpose |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS58140013A JPS58140013A (en) | 1983-08-19 |
JPH0158165B2 true JPH0158165B2 (en) | 1989-12-11 |
Family
ID=12027368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2044982A Granted JPS58140013A (en) | 1982-02-10 | 1982-02-10 | Preparation for external purpose |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS58140013A (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH072618B2 (en) * | 1985-12-09 | 1995-01-18 | 株式会社小林コ−セ− | Makeup remover |
WO1994017780A1 (en) * | 1993-02-11 | 1994-08-18 | Beiersdorf Ag | Waterproof cosmetic or dermatological photoprotective preparations |
US6864274B2 (en) * | 1999-07-23 | 2005-03-08 | Alwyn Company, Inc. | Allantoin-containing skin cream |
US6281236B1 (en) * | 1999-07-23 | 2001-08-28 | Alwyn Company, Inc. | Oil-in-water emulsion with improved stability |
US20020055531A1 (en) * | 1999-07-23 | 2002-05-09 | Elliott Farber | Methods for treatment of inflammatory diseases |
US6329413B1 (en) * | 1999-07-23 | 2001-12-11 | Alwyn Company, Inc. | Allantoin-containing skin cream |
US6896897B2 (en) | 1999-07-23 | 2005-05-24 | Alwyn Company, Inc. | Flexible applicator for applying oil-in-water emulsion with improved stability |
US20020054895A1 (en) * | 1999-07-23 | 2002-05-09 | Alwyn Company, Inc. | Allantoin-containing skin cream |
CA2408689A1 (en) * | 2000-05-12 | 2001-11-22 | Alwyn Company, Inc. | Allantoin-containing skin cream |
US20140135372A1 (en) | 2010-02-02 | 2014-05-15 | Elliott Farber | Compositions and methods of treatment of inflammatory skin conditions using allantoin |
-
1982
- 1982-02-10 JP JP2044982A patent/JPS58140013A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS58140013A (en) | 1983-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS60142920A (en) | Anti-acne agent | |
JPH02121915A (en) | Waterproofing cream conditioner | |
JPH08208488A (en) | Skin preparation for external use | |
CA2216574C (en) | High electrolyte content oil-in-water emulsion and its use for dermatological/cosmetic purposes, specifically for treating irritated and/or sensitive skin. | |
KR20100041684A (en) | Self tanning compositions containing dihydroxyacetone, a retinoid and ascorbic acid glucoside as a stabilizer | |
JPH03220129A (en) | Sebum suppressant | |
CA3111314A1 (en) | Semi-solid oil-based pharmaceutical compositions containing pirfenidone for application in tissue repair | |
JPH0158165B2 (en) | ||
JPH03178916A (en) | Skin external agent | |
AU2009256524B2 (en) | Compositions for treating rosacea comprising chitosan and a dicarboxylic acid | |
JPS6360910A (en) | Skin drug for external use | |
KR100638054B1 (en) | Cosmetic composition for moisturizing skin containing mixed composition of xylitylpolyglucoside, xylitan and xylitol | |
JPS6026086B2 (en) | cosmetics | |
JPS60116618A (en) | Cosmetic | |
JPS6256411A (en) | Beautifying agent | |
JP3057207B2 (en) | External preparation for skin | |
JPH01100114A (en) | External preparation for skin | |
JPH0429934A (en) | Externally applicable composition containing extracted essence of ginkgo leaf | |
KR20210050957A (en) | Cosmetic composition of sunscreen with titanium dioxide powder dispersed in both of oil phase and water phase | |
JPH01100113A (en) | External preparation for skin | |
JP2522803B2 (en) | Cosmetics | |
JP3215133B2 (en) | Anti-inflammatory analgesic external preparation | |
JPS60116616A (en) | Cosmetic | |
JPH0692833A (en) | Skin external agent | |
JPH10316523A (en) | Oil-in-water type emilsified composition |